Prayagraj: Make Alma Mater Proud, Holders of PhD from Allahabad University will now help the UAE take the challenge of treating cancer.
He will prepare people’s genetic data in the UAE and make drugs made specifically for their cancer and many other complex diseases.
Ritambhara has been chosen as a scientist by the G-42 Health Center in Dubai on the annual package of Rs 50 Lakh.
He recently completed his doctoral research under the direction of Munish Kumar Pandey, assistant professor of the Biochemistry Department at the University of Allahabad.
According to his guidance, Profunh Kumar Pandey, “Genome becomes an effective platform for the treatment of severe diseases.
The important link is the study of the human genome and the analysis of the relationship between genes and gene genomics.” The genomics are the study of all genomes (genomes) of individuals.
, including the relationship between genes with each other and with exposure to the individual environment.
He further explained that genomics and all sequencing genomes change health services and give us the opportunity to understand complex diseases such as cancer, medical medicine and personalized treatment.
Ritambhara, azamgarh native, completed his PhD in 2020 and teacher in 2013 from the Biochemistry Department, AU.
He did school and graduated from Varanasi.
His father had a grocery store in Varanasi.
After completing his PhD, he joined Thyrocare in Mumbai as a scientific officer and after four months in the job, he moved to the UAE and joined the G-42 Healthcare Company in the Genome Sequencing Laboratory.
A project manager at a company based in the UAE, he was working on the UAE government project.
The UAE government has entrusted its company with the work of surveying people based on their genomics and made them aware of the possibility of being infected with various types of cancer (based on genome sequencing and environmental elements).
This project also involves suggesting a series of drugs that have no side effects.
Ritambara will carry out the sequencing of all genomes and prepare the genetic data of the people there.
He will then work to make drugs that are beneficial for genetic abnormalities, complex diseases, disorders related to lifestyle and cancer, telling their guidelines.